Yıl: 2021 Cilt: 27 Sayı: 4 Sayfa Aralığı: 389 - 394 Metin Dili: İngilizce DOI: 10.14744/tjtes.2020.58901 İndeks Tarihi: 18-05-2022

The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model

Öz:
BACKGROUND: The free oxygen radicals formed with reperfusion following intestinal ischaemia are extremely toxic for the cells. Glutathione peroxidase, an important enzyme that prevents the formation of reactive oxygen species, requires selenium as a co-factor. This study aims to demonstrate the effects of selenium administration on reducing ischaemia-reperfusion damage. METHODS: In this study, 28 male Wistar rats were separated into four groups. To Groups 3 and 4, sodium selenite at the dose of 10 µg/kg/day was administered intraperitoneally for five days. In Groups 1 and 3, laparotomy was applied, and in Groups 2 and 4, following laparotomy, ischaemia was created by clamping the superior mesenteric artery for 45 mins, then reperfusion was provided for 90 mins. Blood, liver and ileum samples were taken from all the animals for examination of malondialdehyde. For examination of bacterial translocation, liver, spleen and mesenteric lymph node tissue samples were taken. A sample taken from the ileum was examined histopathologically. RESULTS: There was determined to be significantly more bacterial translocation in the mesenteric lymph nodes of the ischaemia-reperfusion group (p<0.05). In the histopathological evaluation, the score in the ischaemia-reperfusion group was significantly higher than the scores in the other groups (p<0.05). Elevated serum, liver and ileum malondialdehyde levels in the ischaemia-reperfusion group were significantly higher than those in the other groups (p<0.05). CONCLUSION: Selenium was seen to have decreased serum and tissue malondialdehyde levels and increased the histopathological damage developing in the intestines with ischaemia-reperfusion and thereby increased bacterial translocation.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Yasuhara H. Acute mesenteric ischemia: the challenge of gastroenterology. Surg Today 2005;35:185–95.
  • 2. Fishman JE, Sheth SU, Levy G, Alli V, Lu Q, Xu D, et al. Intraluminal nonbacterial intestinal components control gut and lung injury after trauma hemorrhagic shock. Ann Surg 2014;260:1112–20.
  • 3. Grace PA. Ischaemia-reperfusion injury. Br J Surg 1994;81:637–47.
  • 4. Kukreja RC, Hess ML. The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc Res 1992;26:641–55.
  • 5. Ornellas FM, Ornellas DS, Martini SV, Castiglione RC, Ventura GM, Rocco PR, et al. Bone marrow-derived mononuclear cell therapy accelerates renal ischemia-reperfusion injury recovery by modulating inflammatory, antioxidant and apoptotic related molecules. Cell Physiol Biochem 2017;41:1736–52.
  • 6. Noack H, Possel H, Chatterjee S, Keilhoff G, Wolf G. Nitrosative stress in primary glial cultures after induction of the inducible isoform of nitric oxide synthase (i-NOS). Toxicology 2000;148:133–42.
  • 7. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000;190:255–66.
  • 8. Rose S, Floyd RA, Eneff K, Bühren V, Massion W. Intestinal ischemia: reperfusion-mediated increase in hydroxyl free radical formation as reported by salicylate hydroxylation. Shock 1994;1:452–6.
  • 9. Gottlieb RA. Cell death pathways in acute ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther 2011;16:233–8.
  • 10. Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH. Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg 2005;18:335–0.
  • 11. Zhu J, Yao K, Wang Q, Guo J, Shi H, Ma L, et al. Ischemic postconditioning-regulated mir-499 protects the rat heart against ischemia/reperfusion injury by inhibiting apoptosis through PDCD4. Cell Physiol Biochem 2016;39:2364–80.
  • 12. Zhi-Yong S, Dong YL, Wang XH. Bacterial translocation and multiple system organ failure in bowel ischemia and reperfusion. J Trauma 1992;32:148–53.
  • 13. Bone RC. Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med 1991;114:332–3.
  • 14. Kelleher ZT, Potts EN, Brahmajothi MV, Foster MW, Auten RL, Foster WM, et al. NOS2 regulation of LPS-induced airway inflammation via S-nitrosylation of NF-{kappa}B p65. Am J Physiol Lung Cell Mol Physiol 2011;301:L327–33.
  • 15. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44–84.
  • 16. Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci 2008;4:89–96.
  • 17. Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull 1993;49:481–93.
  • 18. Southorn PA, Powis G. Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clin Proc 1988;63:381–9.
  • 19. Webster NR, Nunn JF. Molecular structure of free radicals and their importance in biological reactions. Br J Anaesth 1988;60:98–108.
  • 20. Vernie LN. Selenium in carcinogenesis. Biochim Biophys Acta 1984;738:203–17.
  • 21. Navarro-Alarcón M, López-Martínez MC. Essentiality of selenium in the human body: relationship with different diseases. Sci Total Environ 2000;249:347–71.
  • 22. Rayman MP. Selenium and human health. Lancet 2012;379:1256–68.
  • 23. Clausen J, Nielsen SA. Comparison of whole blood selenium values and erythrocyte glutathione peroxidase activities of normal individuals on supplementation with selenate, selenite, L-selenomethionine, and high selenium yeast. Biol Trace Elem Res 1988;15:125–38.
  • 24. Tanguy S, Morel S, Berthonneche C, Toufektsian MC, de Lorgeril M, Ducros V, et al. Preischemic selenium status as a major determinant of myocardial infarct size in vivo in rats. Antioxid Redox Signal 2004;6:792–6.
  • 25. Xing Y, Liu Z, Yang G, Gao D, Niu X. MicroRNA expression profiles in rats with selenium deficiency and the possible role of the Wnt/β-catenin signaling pathway in cardiac dysfunction. Int J Mol Med 2015;35:143–52.
  • 26. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 1970;101:478–83.
  • 27. Morgan RA, Manning PB, Coran AG, Drongowski RA, Till GO, Ward PD, et al. Oxygen free radical activity during live E. coli septic shock in the dog. Circ Shock 1988;25:319–23.
  • 28. Hammouda AE, Soliman SF, Tolba KA, el-Kabbany ZA, Makhlouf MS. Plasma concentrations of lipid peroxidation products in children with acute lymphoblastic leukemia. Clin Chem 1992;38:594–5.
  • 29. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271–8.
  • 30. Mengübaş K, Diab NA, Gökmen G, Ataman OY, Cavdar A, Cin S. Selenium status of healthy Turkish children. Biol Trace Elem Res 1996;54:163–72.
  • 31. Abu-Amara M, Gurusamy KS, Hori S, Glantzounis G, Fuller B, Davidson BR. Pharmacological interventions versus no pharmacological intervention for ischaemia reperfusion injury in liver resection surgery performed under vascular control. Cochrane Database Syst Rev 2009;(4):CD007472.
  • 32. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159–63.
  • 33. Reilly PM, Schiller HJ, Bulkley GB. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 1991;161:488–503.
  • 34. Toufektsian MC, Boucher F, Pucheu S, Tanguy S, Ribuot C, Sanou D, et al. Effects of selenium deficiency on the response of cardiac tissue to ischemia and reperfusion. Toxicology 2000;148:125–32.
  • 35. Border JR, Hassett J, LaDuca J, Seibel R, Steinberg S, Mills B, et al. The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU. Ann Surg 1987;206:427–48.
  • 36. Tassopoulos A, Chalkias A, Papalois A, Iacovidou N, Xanthos T. The effect of antioxidant supplementation on bacterial translocation after intestinal ischemia and reperfusion. Redox Rep 2017;22:1–9.
  • 37. Soncul H, Kaptanoğlu M, Oz E, Halit V, Bilgehan A, Cayci B, et al. The role of selenium added to pulmonary preservation solutions in isolated guinea pig lungs. J Thorac Cardiovasc Surg 1994;108:922–7.
  • 38. Oztürk C, Avlan D, Cinel I, Cinel L, Unlü A, Camdeviren H, et al. Selenium pretreatment prevents bacterial translocation in rat intestinal ischemia/reperfusion model. Pharmacol Res 2002;46:171–5.
  • 39. Schoenberg MH, Beger HG. Reperfusion injury after intestinal ischemia. Crit Care Med 1993;21:1376–86.
  • 40. Bauer P, Belleville-Nabet F, Watelet F, Dubois F, Larcan A. Selenium, oxygen-derived free radicals, and ischemia-reperfusion injury. An experimental study in the rat. Biol Trace Elem Res 1995;47:157–63.
  • 41. Akman H, Somuncu S, Dikmen G, Ayva Ş, Soyer T, Doğan P, et al. Protective effect of selenium on intussusception-induced ischemia/reperfusion intestinal oxidative injury in rats Turk J Med Sci 2010;40:391–7.
  • 42. Erbil G, Ozbal S, Sonmez U, Pekcetin C, Tugyan K, Bagriyanik A, et al. Neuroprotective effects of selenium and ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain. Neurosciences (Riyadh) 2008;13:233–8.
  • 43. Mehta SL, Kumari S, Mendelev N, Li PA. Selenium preserves mitochondrial function, stimulates mitochondrial biogenesis, and reduces infarct volume after focal cerebral ischemia. BMC Neurosci 2012;13:79.
  • 44. Lelli JL Jr, Pradhan S, Cobb LM. Prevention of postischemic injury in immature intestine by deferoxamine. J Surg Res 1993;54:34–8.
  • 45. Albrecht S, Zimmermann T, Ockert D, Oelschläger S, Heinzmann J, Schilling JU. Does selenium prevent peroxynitrite formation from NO in vascular surgery interventions? A clinical study. [Article in German]. Med Klin (Munich) 1997;92:10–1.
APA Yıldırım E, Ozer H, Ozer i, Koyuncu A, YILDIRIM T (2021). The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model. , 389 - 394. 10.14744/tjtes.2020.58901
Chicago Yıldırım Emine,Ozer Hilal,Ozer ilter,Koyuncu Adil,YILDIRIM Timur The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model. (2021): 389 - 394. 10.14744/tjtes.2020.58901
MLA Yıldırım Emine,Ozer Hilal,Ozer ilter,Koyuncu Adil,YILDIRIM Timur The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model. , 2021, ss.389 - 394. 10.14744/tjtes.2020.58901
AMA Yıldırım E,Ozer H,Ozer i,Koyuncu A,YILDIRIM T The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model. . 2021; 389 - 394. 10.14744/tjtes.2020.58901
Vancouver Yıldırım E,Ozer H,Ozer i,Koyuncu A,YILDIRIM T The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model. . 2021; 389 - 394. 10.14744/tjtes.2020.58901
IEEE Yıldırım E,Ozer H,Ozer i,Koyuncu A,YILDIRIM T "The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model." , ss.389 - 394, 2021. 10.14744/tjtes.2020.58901
ISNAD Yıldırım, Emine vd. "The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model". (2021), 389-394. https://doi.org/10.14744/tjtes.2020.58901
APA Yıldırım E, Ozer H, Ozer i, Koyuncu A, YILDIRIM T (2021). The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model. Ulusal Travma ve Acil Cerrahi Dergisi, 27(4), 389 - 394. 10.14744/tjtes.2020.58901
Chicago Yıldırım Emine,Ozer Hilal,Ozer ilter,Koyuncu Adil,YILDIRIM Timur The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model. Ulusal Travma ve Acil Cerrahi Dergisi 27, no.4 (2021): 389 - 394. 10.14744/tjtes.2020.58901
MLA Yıldırım Emine,Ozer Hilal,Ozer ilter,Koyuncu Adil,YILDIRIM Timur The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model. Ulusal Travma ve Acil Cerrahi Dergisi, vol.27, no.4, 2021, ss.389 - 394. 10.14744/tjtes.2020.58901
AMA Yıldırım E,Ozer H,Ozer i,Koyuncu A,YILDIRIM T The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model. Ulusal Travma ve Acil Cerrahi Dergisi. 2021; 27(4): 389 - 394. 10.14744/tjtes.2020.58901
Vancouver Yıldırım E,Ozer H,Ozer i,Koyuncu A,YILDIRIM T The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model. Ulusal Travma ve Acil Cerrahi Dergisi. 2021; 27(4): 389 - 394. 10.14744/tjtes.2020.58901
IEEE Yıldırım E,Ozer H,Ozer i,Koyuncu A,YILDIRIM T "The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model." Ulusal Travma ve Acil Cerrahi Dergisi, 27, ss.389 - 394, 2021. 10.14744/tjtes.2020.58901
ISNAD Yıldırım, Emine vd. "The effects on bacterial translocation and tissue damage of selenium treatment in an experimental intestinal ischaemia-reperfusion model". Ulusal Travma ve Acil Cerrahi Dergisi 27/4 (2021), 389-394. https://doi.org/10.14744/tjtes.2020.58901